Results 1 to 10 of about 2,249 (120)

Association of Serum Mannose-Binding Lectin, Anti-Phospholipase A2 Receptor Antibody and Renal Outcomes in Idiopathic Membranous Nephropathy and Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study [PDF]

Renal Failure, 2022
Objectives Idiopathic membranous nephropathy (iMN) is a major cause of nephrotic syndrome. Atypical membranous nephropathy (aMN) is a new type of nephropathy in China, characterized by a ‘full-house’ on immunofluorescent examination, that is IgG, IgA ...
Li Zuo, Yu Yan, Yina Wang
exaly   +4 more sources

The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study [PDF]

International Journal of General Medicine, 2023
Yanan Liu, Shuo Zhang, Rongrong Hu, Chao Li, Gang Chen, Xiaoxiao Shi, Yan Liu, Ke Zheng, Hang Li, Yubing Wen, Xuemei Li, Xuewang Li, Peng Xia, Yan Qin Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese ...
Chao Li, Yan Qin, Xiaoxiao Shi
exaly   +4 more sources

Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study [PDF]

BMC Nephrology, 2021
Background Membranous nephropathy (MN) is mainly classified into idiopathic MN (iMN) and secondary MN in etiology. In recent years, a new kind of membranous nephropathy, atypical membranous nephropathy (aMN) which shows “full house” in immunofluorescence
Zhenbin Jiang, Meishun Cai, Bao Dong, Yu Yan, Yina Wang, Xin Li, Chunying Shao, Li Zuo   +7 more
doaj   +2 more sources

Clinical significance of renal histological diagnosis in patients with type 2 diabetes and proteinuria atypical for diabetic nephropathy [PDF]

Journal of Diabetes Investigation
Background/Aim Most patients with proteinuria are considered to have typical diabetic nephropathy (DN). However, when proteinuria occurs without diabetic retinopathy, with hematuria, or persists despite strict glycemic and blood pressure control, it is ...
Shogo Kuwagata, Masami Chin‐Kanasaki, Aki Yamada, Tomonori Sakae, Nahomi Ishimoto, Yoshimi Imamura‐Uehara, Kosuke Yamahara, Mako Yasuda‐Yamahara, Sho Sugahara, Yuki Tanaka‐Sasaki, Natsumi Kuwata, Kimihiro Nishimura, Koichiro Murata, Itsuko Miyazawa, Shogo Ida, Natsuko Ohashi, Shinji Kume   +16 more
doaj   +2 more sources

Optimization of a Target Antigen Diagnostic Pathway for Membranous Nephropathy [PDF]

Kidney International Reports
Introduction: The recent Mayo Clinic consensus proposed a target antigen-based diagnostic pathway for membranous nephropathy (MN), recommending testing for neural epidermal growth factor-like 1 (NELL1) following a negative phospholipase A2 receptor ...
Wangyang Li, Cheng Huang, Shuling Yue, Qingqing Rao, Xun Qin, Haofei Hu, Lin Wang, Ji Cen, Ricong Xu, Haiying Song, Yi Xu, Xiuli Zhang, Xiangyang Wang, Xu Dong, Yuan Cheng, Qijun Wan   +15 more
doaj   +2 more sources

Hypokalemic distal tubulopathy secondary to PLA2R-positive membranous nephropathy: an exceptional case [PDF]

Glomerular Diseases
Introduction: Primary membranous nephropathy, one of the most common primary nephrotic syndromes in adults, rarely has tubular involvement.
Thanawat Vongchaiudomchoke, Boonyarit Cheunsuchon, Nuttaya Wachiraphansakul   +2 more
doaj   +2 more sources

Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia [PDF]

Kidney Medicine
A growing number of target antigens have been identified in membranous nephropathy (MN) in recent years. Clinical correlations exist for some MN antigens, whereas others remain poorly characterized because of their rarity.
Jonathan E. Zuckerman, Sarah Larson, Lama Abdelnour   +2 more
doaj   +2 more sources

Contrasting outcomes of visceral leishmaniasis in two patients with membranous nephropathy receiving immunosuppressive therapy: a case report [PDF]

Frontiers in Immunology
BackgroundVisceral leishmaniasis (VL) often presents with an atypical and fulminant course in immunocompromised hosts, and treatment faces multiple challenges including drug toxicity, immunosuppressive status, and complications.Case presentationHere we ...
Xiu Sun, Yan Wang, Ruixian Duan
doaj   +2 more sources

Application of C5 inhibitors in glomerular diseases in 2021 [PDF]

Kidney Research and Clinical Practice, 2022
The complement pathway is an essential mechanism in innate immunity, but it is also involved in multiple pathologies. For kidney diseases, strong evidence of a dysregulation in the alternative pathway in atypical hemolytic uremic syndrome (aHUS) led to ...
Alexis Werion, Eric Rondeau
doaj   +1 more source

Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature

Frontiers in Immunology, 2022
Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia, thrombocytopenia and organ injury occurring due to endothelial cell damage and microthrombi formation in small vessels.
Maryam Saleem, Sana Shaikh, Zheng Hu, Nicola Pozzi, Anuja Java   +4 more
doaj   +1 more source